| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oncolytics Biotech Inc. (ONCY) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. ONCY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 567.0K | $510.3K | - | |
| Dir | 492.4K | $443.2K | - | |
| CFO | 287.5K | $258.8K | - | |
| Other | 282.8K | $254.5K | - | |
| VP | 115.1K | $103.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Aromando Andrew | Chief Business Officer | Buy | 29,600 | $0.86 | $25,417.52 | +116.1% | - | - | |
| Jan 16, 2026 | Seizinger Bernd R.49 | Director | Buy | 100,000 | $1.04 | $103,770.00 | +27.2% | - | - |